Biomaterial Database

In-transit metastases: the migration of melanoma. 2020

Abirami Pararajasingam, and Richard Goodwin

Department of Dermatology, St Woolos Hospital, Newport, UK.

UI	MeSH Term	Description	Entries
D008297	Male		Males
D008545	Melanoma	A malignant neoplasm derived from cells that are capable of forming melanin, which may occur in the skin of any part of the body, in the eye, or, rarely, in the mucous membranes of the genitalia, anus, oral cavity, or other sites. It occurs mostly in adults and may originate de novo or from a pigmented nevus or malignant lentigo. Melanomas frequently metastasize widely, and the regional lymph nodes, liver, lungs, and brain are likely to be involved. The incidence of malignant skin melanomas is rising rapidly in all parts of the world. (Stedman, 25th ed; from Rook et al., Textbook of Dermatology, 4th ed, p2445)	Malignant Melanoma,Malignant Melanomas,Melanoma, Malignant,Melanomas,Melanomas, Malignant
D009362	Neoplasm Metastasis	The transfer of a neoplasm from one organ or part of the body to another remote from the primary site.	Metastase,Metastasis,Metastases, Neoplasm,Metastasis, Neoplasm,Neoplasm Metastases,Metastases
D006801	Humans	Members of the species Homo sapiens.	Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000074322	Antineoplastic Agents, Immunological	Antineoplastic agents containing immunological agents (e.g. MAbs). These pharmacologic preparations inhibit or prevent the proliferation of NEOPLASMS.	Antineoplastic MAbs,Antineoplastics, Monoclonal Antibodies,Antineoplastics, Monoclonal Antibody,MAbs, Antineoplastic,Monoclonal Antibodies, Antineoplastic,Antibodies Antineoplastics, Monoclonal,Antineoplastic Monoclonal Antibodies,Immunological Antineoplastic Agents,Monoclonal Antibodies Antineoplastics,Monoclonal Antibody Antineoplastics
D000368	Aged	A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available.	Elderly
D012878	Skin Neoplasms	Tumors or cancer of the SKIN.	Cancer of Skin,Skin Cancer,Cancer of the Skin,Neoplasms, Skin,Cancer, Skin,Cancers, Skin,Neoplasm, Skin,Skin Cancers,Skin Neoplasm
D061067	Antibodies, Monoclonal, Humanized	Antibodies from non-human species whose protein sequences have been modified to make them nearly identical with human antibodies. If the constant region and part of the variable region are replaced, they are called humanized. If only the constant region is modified they are called chimeric. INN names for humanized antibodies end in -zumab.	Antibodies, Humanized,Humanized Antibodies

Related Publications

Abirami Pararajasingam, and Richard Goodwin

In-transit melanoma metastases.

July 2019, International journal of dermatology,

Abirami Pararajasingam, and Richard Goodwin

In-transit metastases from malignant melanoma.

January 2017, The National medical journal of India,

Abirami Pararajasingam, and Richard Goodwin

Management of in-transit melanoma metastases: a review.

June 2019, ANZ journal of surgery,

Abirami Pararajasingam, and Richard Goodwin

Diagnosis and treatment of in-transit melanoma metastases.

March 2017, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology,

Abirami Pararajasingam, and Richard Goodwin

Treatment of melanoma in-transit metastases confined to the limb.

January 1996, Cancer surveys,

Abirami Pararajasingam, and Richard Goodwin

Management of in-transit metastases from cutaneous malignant melanoma.

June 2004, The British journal of surgery,

Abirami Pararajasingam, and Richard Goodwin

Local and intralesional therapy of in-transit melanoma metastases.

September 2011, Journal of surgical oncology,

Abirami Pararajasingam, and Richard Goodwin

In-transit melanoma metastases: incidence, prognosis, and the role of lymphadenectomy.

February 2015, Annals of surgical oncology,